A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins

Nature Immunology

Volumn 2, Issue 6, 2001, Pages 493-500

  Miyazaki, Tadaaki ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 8; CASPASE 9; DAP3 PROTEIN, HUMAN; ENZYME PRECURSOR; FADD PROTEIN, HUMAN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GUANOSINE TRIPHOSPHATE; MEMBRANE PROTEIN; PROTEIN; RECOMBINANT PROTEIN; RIBOSOME PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL; APOPTOSIS; ARTICLE; BINDING SITE; CELL LINE; CELL STRAIN COS1; CHEMISTRY; ENZYME ACTIVATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TWO HYBRID SYSTEM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; CARRIER PROTEINS; CASPASE 8; CASPASE 9; CASPASES; CELL LINE; COS CELLS; ENZYME ACTIVATION; ENZYME PRECURSORS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GUANOSINE TRIPHOSPHATE; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECOMBINANT PROTEINS; RIBOSOMAL PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0035374366     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/88684     Document Type: Article

References (49)

1. Nagata, S. Fas-induced apoptosis, and diseases caused by its abnormality. Genes Cells 1, 873-879 (1996).
2. Wang, J. & Lenardo, M. J. Molecules involved in cell death and peripheral tolerance. Curr. Opin. Immunol. 9, 818-825 (1997).
3. Ashkenazi, A. & Dixit, V. Death receptors: signaling and modulation. Science 281, 1305-1308 (1998).
4. Griffith, T. S. & Lynch, D. H. TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10, 559-563 (1998).
5. Walczak, H. & Krammer, P. H. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256, 58-66 (2000).
6. + T cell killing of antigen-presenting macrophages. J. Immunol. 164, 2897-2904 (2000).
7. Kayagaki, N. et al. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189, 1451-1460 (1999).
8. Zamai, L et al. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188, 2375-2380 (1998).
9. Griffith, T. S. et al. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J. Exp. Med. 189, 1343-1354 (1999).
10. Fanger, N. A., Maliszewski, C. R., Schooley, K. & Griffith, T. S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190, 1155-1164 (1999).
11. Clarke, P. et al. Reovirus-induced apoptosis is mediated by TRAIL. J. Virol. 74, 8135-8139 (2000).
12. Vidalain, P. O. et al. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74, 556-559 (2000).
13. Sedger, L. M. et al. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 163, 920-926 (1999).
14. Song, K. et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191, 1095-1103 (2000).
15. Marsters, S. A. Pitti, R. A., Sheridan, J. P. & Ashkenazi, A. Control of apoptosis signaling by Apo2 ligand. Rec. Prog. Hor. Res. 54, 225-234 (1999).
16. French, L. E. & Tschopp, J. The TRAIL to selective tumor death. Nature Med. 5, 157-163 (1999).
17. Degli-Esposti, M. To die or not to die - the quest of the TRAIL receptors. J. Leuko. Biol. 65, 535-542 (1999).
18. Peter, M. E. The TRAIL DISCussion: it is FADD and caspase-8! Cell Death Differ. 7, 759-760 (2000).
19. Wallach, D. et al. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17, 331-367 (1999).
20. Salvesen, G. S. & Dixit, V. M. Caspase activation: the induced-proximity model. Proc. Natl Acad. Sci. USA 96, 10964-10967 (1999).
21. Kuang, A. A., Diehl, G. E., Zhang, J. & Winoto, A. FADD is required for DR4- and DR5-mediated apoptosis: lack of TRAIL-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J. Biol. Chem. 175, 25065-25068 (2000).
22. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. & Wallach, D. Involvement of MACH, a novel MORTI/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815 (1996).
23. Muzio, M. et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death - inducing signaling complex. Cell 85, 817-827 (1996).
24. Schneider, R et al. TRAIL receptors I (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7, 831-836 (1997).
25. Walczak, H. et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16, 5386-5397 (1997).
26. Kischkel, F. C. et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611-620 (2000).
27. Sprick, M. R. et al. FADD/MORTI and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12, 599-609 (2000).
28. Kissil, J. L. et al. Isolation of DAP3, a novel mediator of interferon-γ-induced cell death. J. Biol. Chem. 270, 27932-27936 (1995).
29. Kissil, J., Cohen, O., Raveh, T. & Kimchi, A. Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-α and Fas-induced cell death. EMBO J. 18, 353-362 (1999).
30. Ni, C.-Z. et al. Molecular basis for CD40 signaling mediated by Traf3. Proc. Natl Acad. Sci. USA 97, 10395-10399 (2000).
31. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. & Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512 (1995).
32. Zhou, Q. et al. Target protease specificity of the viral serpin CrmA: analysis of five caspases. J. Biol. Chem 272, 7797-7800 (1997).
33. Thornberry, N. et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. J. Biol. Chem. 272, 17907-17911 (1997).
34. Miyazaki, T. et al. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266, 1045-1047 (1994).
35. Berglund, H. et al. The three-dimensional solution structure and dynamic properties of the human FADD death domain. J. Mol. Biol. 302, 171-188 (2000).
36. Varfolomeeve, E. E., Boldin, M. P., Goncharov, T. M. & Wallach, D. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APOI: Proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 183, 1271-1275 (1996).
37. Jeong, E. J. et al. The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD. J. Biol. Chem. 274, 16337-16342 (1999).
38. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G. & Alnemri, E. S. Molecular ordering of the fas-apoptotic pathway: The fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc.Natl Acad. Sci. USA 93, 14486-14491 (1996).
39. Hulkko, S., Wakui, H. & Zilliacus, J. The pro-apoptotic protein death-associated protien 3 (DAP3) interacts with the glucocorticoid receptor and affects the receptor function. Biochem. J. 349, 885-893 (2000).
40. Moreno, M. B., Memon, S. A. & Zacharchuk, C. M. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and ICE-family protease inhibitors on glucocorticoid-and Fas-mediated cytotoxicity. J. Immunol. 157, 3845-3349 (1996).
41. Berger, T. et al. The apoptosis mediator mDAP-3 is a novel member of a conserved family of mitochondrial proteins. J. Cell Sci. 113, 3603-3612 (2000).
42. Yang, X., Chang, H. & Baltimore, D. Essential role of CED-4 oligomerization in CED-3 activation and apoptosis. Science 281, 1355-1357 (1998).
43. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T. & Alnemri, E. S. Autoactivation of pro-caspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1, 949-957 (1998).
44. Torii, S., Egan, D., Evans, R. & Reed, J. Human daxx regulates fas-induced apoptosis from nuclear pml oncogenic domains (pods). EMBO J. 18, 6037-6049 (1999).
45. Estojak, J., Brent, R. & Golemis, E. A. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell Biol. 15, 5820-5829 (1995).
46. Schneider, P. et al. Characterization of two receptors for TRAIL. FEBS Lett. 416, 329-334 (1997).
47. Matsuzawa, S., Takayama, S., Froesch, B. A., Zapata, J. M. & Reed, J. C. p53-inducible human homologue of Drosophila seven in absentia (Siah) inhibits cell growth: suppression by BAG-1. EMBO J. 17, 2736-2747 (1998).
48. Haraguchi, M. et al. APAF-1 independent cell death suppression by Bcl-2. J. Exp. Med. 191, 1709-1720 (2000).
49. Cardone, M. et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321 (1998).